A sample course that uses engagement time for credit-Video 1

Video Transcription

Video Summary

Dr. Madi Schnur discusses the importance of patient selection for neuromodulation devices. She explains that selecting the right patients can improve long-term relief and reduce treatment failure rates. Treatment failure not only leads to patient dissatisfaction but also incurs additional costs for device removal. Dr. Schnur emphasizes the need to follow FDA-approved indications and ensure a positive response to a trial before placing a permanent device. Factors such as patient safety, pregnancy, and patient understanding of device operation should also be considered. Dr. Schnur provides examples of common indications for different devices, including spinal cord stimulation, dorsal root ganglion stimulation, intrathecal pain pumps, and peripheral nerve stimulation. Psychological risk factors, patient demographics like BMI and smoking, and medication use (such as opioids) should also be evaluated when selecting patients. Finally, Dr. Schnur discusses guidelines, such as the NAC guidelines and PAC guidelines, for infection prevention and management, as well as the importance of staying updated on current guidelines for device implantation.

Keywords

patient selection

neuromodulation devices

treatment failure rates

FDA-approved indications

device removal

spinal cord stimulation